Jeffrey W. Taub, M.D. – FDA Inspection, Oct 12, 2022

Record Details

This FDA Inspection record concerns Jeffrey W. Taub, M.D., with an inspection on October 12, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Jeffrey W. Taub, M.D.
Inspection Date: October 12, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · 25e0115e-300a-48da-a475-6f556a4bc774

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1181368
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.66Initial and continuing review

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jeffrey W. Taub, M.D.

FDA Inspection

Jeffrey W. Taub, M.D.October 12, 2022